Clinical Trial Update: CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of CI-1040 in advanced breast cancer, colorectal cancer, pancreatic cancer, and non-small cell lung cancer has completed. Sponsor: University of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• CI-1040 (CI-1040)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Breast Cancer, Colorectal Cancer | Phase 2 | Status: COMPLETED